| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | allyl-alcohol dehydrogenase activity | 7.46e-08 | 4 | 54 | 3 | GO:0047655 | |
| GeneOntologyMolecularFunction | I-SMAD binding | 1.11e-07 | 17 | 54 | 4 | GO:0070411 | |
| GeneOntologyMolecularFunction | DEAD/H-box RNA helicase binding | 1.55e-06 | 9 | 54 | 3 | GO:0017151 | |
| GeneOntologyMolecularFunction | medium-chain fatty acid-CoA ligase activity | 3.04e-06 | 11 | 54 | 3 | GO:0031956 | |
| GeneOntologyMolecularFunction | co-SMAD binding | 4.04e-06 | 12 | 54 | 3 | GO:0070410 | |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 6.66e-06 | 14 | 54 | 3 | GO:0001758 | |
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 6.66e-06 | 14 | 54 | 3 | GO:0004032 | |
| GeneOntologyMolecularFunction | ligase activity | 7.33e-06 | 174 | 54 | 6 | GO:0016874 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NADP+) activity | 8.31e-06 | 15 | 54 | 3 | GO:0052650 | |
| GeneOntologyMolecularFunction | benzoate-CoA ligase activity | 2.15e-05 | 3 | 54 | 2 | GO:0018858 | |
| GeneOntologyMolecularFunction | indanol dehydrogenase activity | 4.29e-05 | 4 | 54 | 2 | GO:0047718 | |
| GeneOntologyMolecularFunction | decanoate-CoA ligase activity | 4.29e-05 | 4 | 54 | 2 | GO:0102391 | |
| GeneOntologyMolecularFunction | fatty acid ligase activity | 4.65e-05 | 26 | 54 | 3 | GO:0015645 | |
| GeneOntologyMolecularFunction | CoA-ligase activity | 5.22e-05 | 27 | 54 | 3 | GO:0016405 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 5.22e-05 | 27 | 54 | 3 | GO:0008106 | |
| GeneOntologyMolecularFunction | acid-thiol ligase activity | 7.96e-05 | 31 | 54 | 3 | GO:0016878 | |
| GeneOntologyMolecularFunction | SMAD binding | 8.61e-05 | 86 | 54 | 4 | GO:0046332 | |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 8.77e-05 | 32 | 54 | 3 | GO:0004033 | |
| GeneOntologyMolecularFunction | geranylgeranyl reductase activity | 1.07e-04 | 6 | 54 | 2 | GO:0045550 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-sulfur bonds | 1.85e-04 | 41 | 54 | 3 | GO:0016877 | |
| GeneOntologyMolecularFunction | fatty-acyl-CoA synthase activity | 1.99e-04 | 8 | 54 | 2 | GO:0004321 | |
| GeneOntologyMolecularFunction | NADP+ binding | 2.55e-04 | 9 | 54 | 2 | GO:0070401 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 2.97e-04 | 48 | 54 | 3 | GO:0016620 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 4.68e-04 | 56 | 54 | 3 | GO:0016903 | |
| GeneOntologyMolecularFunction | estradiol 17-beta-dehydrogenase [NAD(P)+] activity | 1.32e-03 | 20 | 54 | 2 | GO:0004303 | |
| GeneOntologyMolecularFunction | C-acyltransferase activity | 1.46e-03 | 21 | 54 | 2 | GO:0016408 | |
| GeneOntologyMolecularFunction | retinal binding | 1.46e-03 | 21 | 54 | 2 | GO:0016918 | |
| GeneOntologyMolecularFunction | NADPH binding | 2.24e-03 | 26 | 54 | 2 | GO:0070402 | |
| GeneOntologyMolecularFunction | R-SMAD binding | 2.24e-03 | 26 | 54 | 2 | GO:0070412 | |
| GeneOntologyMolecularFunction | transforming growth factor beta receptor binding | 3.17e-03 | 31 | 54 | 2 | GO:0005160 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 3.59e-03 | 33 | 54 | 2 | GO:0033764 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 4.92e-03 | 127 | 54 | 3 | GO:0016616 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity | 4.99e-03 | 39 | 54 | 2 | GO:0016229 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-oxygen bonds | 5.77e-03 | 42 | 54 | 2 | GO:0016875 | |
| GeneOntologyMolecularFunction | aminoacyl-tRNA ligase activity | 5.77e-03 | 42 | 54 | 2 | GO:0004812 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 6.19e-03 | 138 | 54 | 3 | GO:0016614 | |
| GeneOntologyMolecularFunction | tau protein binding | 6.88e-03 | 46 | 54 | 2 | GO:0048156 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a tRNA | 6.96e-03 | 144 | 54 | 3 | GO:0140101 | |
| GeneOntologyMolecularFunction | acetylglucosaminyltransferase activity | 7.18e-03 | 47 | 54 | 2 | GO:0008375 | |
| GeneOntologyMolecularFunction | retinoid binding | 7.48e-03 | 48 | 54 | 2 | GO:0005501 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4,5-trisphosphate binding | 7.78e-03 | 49 | 54 | 2 | GO:0005547 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 7.78e-03 | 49 | 54 | 2 | GO:0019840 | |
| GeneOntologyMolecularFunction | vitamin binding | 9.45e-03 | 161 | 54 | 3 | GO:0019842 | |
| GeneOntologyBiologicalProcess | primary miRNA processing | 1.77e-05 | 20 | 53 | 3 | GO:0031053 | |
| GeneOntologyBiologicalProcess | embryonic pattern specification | 8.80e-05 | 91 | 53 | 4 | GO:0009880 | |
| GeneOntologyBiologicalProcess | osteoblast fate commitment | 9.65e-05 | 6 | 53 | 2 | GO:0002051 | |
| GeneOntologyBiologicalProcess | ureteric bud development | 1.65e-04 | 107 | 53 | 4 | GO:0001657 | |
| GeneOntologyBiologicalProcess | positive regulation of type I hypersensitivity | 1.80e-04 | 8 | 53 | 2 | GO:0001812 | |
| GeneOntologyBiologicalProcess | mesonephric tubule development | 1.83e-04 | 110 | 53 | 4 | GO:0072164 | |
| GeneOntologyBiologicalProcess | mesonephric epithelium development | 1.83e-04 | 110 | 53 | 4 | GO:0072163 | |
| GeneOntologyBiologicalProcess | SMAD protein signal transduction | 1.83e-04 | 110 | 53 | 4 | GO:0060395 | |
| GeneOntologyBiologicalProcess | mesonephros development | 2.03e-04 | 113 | 53 | 4 | GO:0001823 | |
| GeneOntologyBiologicalProcess | regulation of type I hypersensitivity | 2.31e-04 | 9 | 53 | 2 | GO:0001810 | |
| GeneOntologyBiologicalProcess | daunorubicin metabolic process | 2.31e-04 | 9 | 53 | 2 | GO:0044597 | |
| GeneOntologyBiologicalProcess | miRNA processing | 2.55e-04 | 48 | 53 | 3 | GO:0035196 | |
| GeneOntologyBiologicalProcess | type I hypersensitivity | 2.88e-04 | 10 | 53 | 2 | GO:0016068 | |
| GeneOntologyBiologicalProcess | doxorubicin metabolic process | 2.88e-04 | 10 | 53 | 2 | GO:0044598 | |
| GeneOntologyBiologicalProcess | polyketide metabolic process | 2.88e-04 | 10 | 53 | 2 | GO:0030638 | |
| GeneOntologyBiologicalProcess | aminoglycoside antibiotic metabolic process | 2.88e-04 | 10 | 53 | 2 | GO:0030647 | |
| GeneOntologyBiologicalProcess | retinol metabolic process | 3.43e-04 | 53 | 53 | 3 | GO:0042572 | |
| GeneOntologyBiologicalProcess | embryonic foregut morphogenesis | 3.51e-04 | 11 | 53 | 2 | GO:0048617 | |
| GeneOntologyBiologicalProcess | foregut morphogenesis | 4.21e-04 | 12 | 53 | 2 | GO:0007440 | |
| GeneOntologyBiologicalProcess | paraxial mesoderm morphogenesis | 4.96e-04 | 13 | 53 | 2 | GO:0048340 | |
| GeneOntologyCellularComponent | heteromeric SMAD protein complex | 2.76e-09 | 8 | 54 | 4 | GO:0071144 | |
| GeneOntologyCellularComponent | SMAD protein complex | 8.25e-09 | 10 | 54 | 4 | GO:0071141 | |
| GeneOntologyCellularComponent | homomeric SMAD protein complex | 6.55e-06 | 2 | 54 | 2 | GO:0071142 | |
| GeneOntologyCellularComponent | mitochondrial matrix | 3.77e-04 | 523 | 54 | 7 | GO:0005759 | |
| HumanPheno | Long fingers | 1.88e-05 | 306 | 16 | 7 | HP:0100807 | |
| Domain | Dwarfin | 4.33e-09 | 8 | 54 | 4 | IPR013790 | |
| Domain | DWB | 4.33e-09 | 8 | 54 | 4 | SM00524 | |
| Domain | - | 4.33e-09 | 8 | 54 | 4 | 3.90.520.10 | |
| Domain | MAD_homology_MH1 | 4.33e-09 | 8 | 54 | 4 | IPR013019 | |
| Domain | MH2 | 4.33e-09 | 8 | 54 | 4 | PS51076 | |
| Domain | MH1 | 4.33e-09 | 8 | 54 | 4 | PS51075 | |
| Domain | MH2 | 4.33e-09 | 8 | 54 | 4 | PF03166 | |
| Domain | SMAD_dom_Dwarfin-type | 4.33e-09 | 8 | 54 | 4 | IPR001132 | |
| Domain | MAD_homology1_Dwarfin-type | 3.04e-08 | 12 | 54 | 4 | IPR003619 | |
| Domain | DWA | 3.04e-08 | 12 | 54 | 4 | SM00523 | |
| Domain | MH1 | 3.04e-08 | 12 | 54 | 4 | PF03165 | |
| Domain | SMAD_dom-like | 1.11e-07 | 16 | 54 | 4 | IPR017855 | |
| Domain | - | 1.11e-07 | 16 | 54 | 4 | 2.60.200.10 | |
| Domain | ALDOKETO_REDUCTASE_1 | 2.70e-06 | 10 | 54 | 3 | PS00798 | |
| Domain | Aldo/ket_reductase_CS | 2.70e-06 | 10 | 54 | 3 | IPR018170 | |
| Domain | Aldo/keto_reductase | 2.70e-06 | 10 | 54 | 3 | IPR020471 | |
| Domain | ALDOKETO_REDUCTASE_2 | 2.70e-06 | 10 | 54 | 3 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 2.70e-06 | 10 | 54 | 3 | PS00063 | |
| Domain | - | 1.25e-05 | 16 | 54 | 3 | 3.20.20.100 | |
| Domain | NADP_OxRdtase_dom | 1.51e-05 | 17 | 54 | 3 | IPR023210 | |
| Domain | Aldo_ket_red | 1.51e-05 | 17 | 54 | 3 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 1.51e-05 | 17 | 54 | 3 | IPR001395 | |
| Domain | AMP-bd_C | 1.51e-05 | 17 | 54 | 3 | IPR025110 | |
| Domain | AMP-binding_C | 1.51e-05 | 17 | 54 | 3 | PF13193 | |
| Domain | SMAD_FHA_domain | 1.52e-05 | 52 | 54 | 4 | IPR008984 | |
| Domain | AMP-binding_CS | 5.67e-05 | 26 | 54 | 3 | IPR020845 | |
| Domain | AMP_BINDING | 7.11e-05 | 28 | 54 | 3 | PS00455 | |
| Domain | AMP-binding | 8.78e-05 | 30 | 54 | 3 | PF00501 | |
| Domain | AMP-dep_Synth/Lig | 8.78e-05 | 30 | 54 | 3 | IPR000873 | |
| Domain | RA | 1.52e-04 | 36 | 54 | 3 | PF00788 | |
| Domain | RA | 1.66e-04 | 37 | 54 | 3 | PS50200 | |
| Domain | RA_dom | 2.09e-04 | 40 | 54 | 3 | IPR000159 | |
| Domain | RA | 3.62e-03 | 31 | 54 | 2 | SM00314 | |
| Domain | PH | 4.31e-03 | 229 | 54 | 4 | PF00169 | |
| Domain | PH | 8.48e-03 | 278 | 54 | 4 | SM00233 | |
| Domain | PH_DOMAIN | 8.58e-03 | 279 | 54 | 4 | PS50003 | |
| Pathway | WP_NEOVASCULARIZATION_PROCESSES | 5.54e-06 | 37 | 45 | 4 | M39506 | |
| Pathway | WP_TGFBETA_SIGNALING_PATHWAY | 2.37e-05 | 53 | 45 | 4 | MM15880 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING | 2.74e-05 | 55 | 45 | 4 | M39351 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 3.53e-05 | 118 | 45 | 5 | MM15588 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 3.63e-05 | 59 | 45 | 4 | M39886 | |
| Pathway | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | 7.51e-05 | 26 | 45 | 3 | MM14878 | |
| Pathway | REACTOME_CONJUGATION_OF_SALICYLATE_WITH_GLYCINE | 1.48e-04 | 6 | 45 | 2 | MM14693 | |
| Pathway | REACTOME_SIGNALING_BY_NODAL | 1.48e-04 | 6 | 45 | 2 | MM14517 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 1.54e-04 | 161 | 45 | 5 | M27871 | |
| Pathway | KEGG_TGF_BETA_SIGNALING_PATHWAY | 1.59e-04 | 86 | 45 | 4 | M2642 | |
| Pathway | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | 2.02e-04 | 36 | 45 | 3 | M633 | |
| Pathway | REACTOME_LOSS_OF_FUNCTION_OF_SMAD2_3_IN_CANCER | 2.07e-04 | 7 | 45 | 2 | M29623 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES | 2.07e-04 | 7 | 45 | 2 | MM15661 | |
| Pathway | REACTOME_AMINO_ACID_CONJUGATION | 2.07e-04 | 7 | 45 | 2 | MM14598 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP15_SIGNALING_PATHWAY | 2.07e-04 | 7 | 45 | 2 | M47845 | |
| Pathway | REACTOME_ESTROGEN_BIOSYNTHESIS | 2.07e-04 | 7 | 45 | 2 | MM14740 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX_IN_CANCER | 2.76e-04 | 8 | 45 | 2 | M27246 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGF_BETA_SIGNALING_PATHWAY | 2.76e-04 | 8 | 45 | 2 | M47415 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NODAL_SIGNALING_PATHWAY | 2.76e-04 | 8 | 45 | 2 | M47849 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACTIVIN_SIGNALING_PATHWAY | 2.76e-04 | 8 | 45 | 2 | M47846 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MYOSTATIN_SIGNALING_PATHWAY | 2.76e-04 | 8 | 45 | 2 | M47847 | |
| Pathway | REACTOME_METABOLISM_OF_STEROID_HORMONES | 2.98e-04 | 41 | 45 | 3 | MM14757 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | 2.98e-04 | 41 | 45 | 3 | MM14876 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AMH_SIGNALING_PATHWAY | 3.54e-04 | 9 | 45 | 2 | M47844 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP9_10_SIGNALING_PATHWAY | 3.54e-04 | 9 | 45 | 2 | M47822 | |
| Pathway | REACTOME_AMINO_ACID_CONJUGATION | 3.54e-04 | 9 | 45 | 2 | M26968 | |
| Pathway | WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING | 3.81e-04 | 108 | 45 | 4 | M48078 | |
| Pathway | WP_ID_SIGNALING_PATHWAY | 5.36e-04 | 50 | 45 | 3 | MM15817 | |
| Pathway | PID_ALK2_PATHWAY | 5.38e-04 | 11 | 45 | 2 | M203 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP_HAMP_SIGNALING_PATHWAY | 5.38e-04 | 11 | 45 | 2 | M47848 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | 5.69e-04 | 51 | 45 | 3 | M665 | |
| Pathway | WP_TGFB_SMAD_SIGNALING | 6.44e-04 | 12 | 45 | 2 | M48091 | |
| Pathway | WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION | 7.60e-04 | 13 | 45 | 2 | M39378 | |
| Pathway | REACTOME_LYSOSPHINGOLIPID_AND_LPA_RECEPTORS | 8.85e-04 | 14 | 45 | 2 | M27331 | |
| Pathway | REACTOME_LYSOSPHINGOLIPID_AND_LPA_RECEPTORS | 8.85e-04 | 14 | 45 | 2 | MM15062 | |
| Pathway | REACTOME_FORMATION_OF_AXIAL_MESODERM | 8.85e-04 | 14 | 45 | 2 | M46441 | |
| Pathway | REACTOME_SIGNALING_BY_ACTIVIN | 1.02e-03 | 15 | 45 | 2 | MM14593 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 1.07e-03 | 142 | 45 | 4 | MM15576 | |
| Pathway | PID_SMAD2_3PATHWAY | 1.16e-03 | 16 | 45 | 2 | M228 | |
| Pathway | REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING | 1.16e-03 | 16 | 45 | 2 | MM14873 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 1.28e-03 | 149 | 45 | 4 | M41805 | |
| Pathway | REACTOME_GERM_LAYER_FORMATION_AT_GASTRULATION | 1.31e-03 | 17 | 45 | 2 | M45017 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING | 1.31e-03 | 17 | 45 | 2 | M39686 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 1.31e-03 | 17 | 45 | 2 | MM1509 | |
| Pathway | REACTOME_FORMATION_OF_DEFINITIVE_ENDODERM | 1.31e-03 | 17 | 45 | 2 | M48030 | |
| Pathway | REACTOME_SIGNALING_BY_ACTIVIN | 1.31e-03 | 17 | 45 | 2 | M26965 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES | 1.31e-03 | 17 | 45 | 2 | M27946 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_ADDITIONAL_CELL_CYCLE_GENES_WHOSE_EXACT_ROLE_IN_THE_P53_PATHWAY_REMAIN_UNCERTAIN | 1.48e-03 | 18 | 45 | 2 | MM15336 | |
| Pathway | WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION | 1.65e-03 | 19 | 45 | 2 | M39370 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 1.65e-03 | 19 | 45 | 2 | M18933 | |
| Pathway | WP_HYPOXIADEPENDENT_PROLIFERATION_OF_MYOBLASTS | 1.65e-03 | 19 | 45 | 2 | MM15811 | |
| Pathway | WP_BMP_SIGNALING_PATHWAY_IN_EYELID_DEVELOPMENT | 1.83e-03 | 20 | 45 | 2 | MM15907 | |
| Pathway | WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT | 1.83e-03 | 20 | 45 | 2 | M39624 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP_SIGNALING_PATHWAY | 1.83e-03 | 20 | 45 | 2 | M47843 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 1.89e-03 | 77 | 45 | 3 | MM14670 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_ADDITIONAL_CELL_CYCLE_GENES_WHOSE_EXACT_ROLE_IN_THE_P53_PATHWAY_REMAIN_UNCERTAIN | 2.01e-03 | 21 | 45 | 2 | M27634 | |
| Pathway | WP_PROGERIAASSOCIATED_LIPODYSTROPHY | 2.21e-03 | 22 | 45 | 2 | M42534 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION | 2.21e-03 | 22 | 45 | 2 | MM15656 | |
| Pathway | REACTOME_SIGNALING_BY_NODAL | 2.42e-03 | 23 | 45 | 2 | M511 | |
| Pathway | REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION | 2.63e-03 | 24 | 45 | 2 | M6591 | |
| Pathway | BIOCARTA_CTCF_PATHWAY | 2.63e-03 | 24 | 45 | 2 | M11420 | |
| Pathway | REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY | 2.63e-03 | 24 | 45 | 2 | MM14877 | |
| Pathway | BIOCARTA_CTCF_PATHWAY | 2.63e-03 | 24 | 45 | 2 | MM1373 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | 2.68e-03 | 768 | 45 | 8 | MM14851 | |
| Pathway | WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE | 2.85e-03 | 25 | 45 | 2 | M39665 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 2.85e-03 | 25 | 45 | 2 | M39713 | |
| Pathway | PID_ALK1_PATHWAY | 3.08e-03 | 26 | 45 | 2 | M185 | |
| Pathway | REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING | 3.08e-03 | 26 | 45 | 2 | M628 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 3.33e-03 | 94 | 45 | 3 | M1041 | |
| Pathway | WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS | 3.83e-03 | 29 | 45 | 2 | M39516 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DYNEIN_RECRUITMENT_TO_THE_KINETOCHORE | 4.09e-03 | 30 | 45 | 2 | M47889 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_OXIDATIVE_STRESS_METABOLIC_AND_NEURONAL_GENES | 4.09e-03 | 30 | 45 | 2 | M27941 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | 4.19e-03 | 649 | 45 | 7 | MM15690 | |
| Pathway | REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY | 4.37e-03 | 31 | 45 | 2 | M669 | |
| Pathway | WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING | 4.37e-03 | 31 | 45 | 2 | MM15818 | |
| Pathway | REACTOME_SIGNALING_BY_BMP | 4.37e-03 | 31 | 45 | 2 | M1662 | |
| Pathway | REACTOME_SIGNALING_BY_BMP | 4.37e-03 | 31 | 45 | 2 | MM14789 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 5.04e-03 | 109 | 45 | 3 | MM15164 | |
| Pathway | KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM | 5.24e-03 | 34 | 45 | 2 | M15898 | |
| Pathway | KEGG_BUTANOATE_METABOLISM | 5.24e-03 | 34 | 45 | 2 | M3397 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES | 5.24e-03 | 34 | 45 | 2 | MM15325 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 5.30e-03 | 111 | 45 | 3 | M27416 | |
| Pathway | WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING | 5.86e-03 | 36 | 45 | 2 | M39569 | |
| Pathway | REACTOME_METABOLISM_OF_STEROID_HORMONES | 5.86e-03 | 36 | 45 | 2 | M27081 | |
| Pathway | BIOCARTA_ALK_PATHWAY | 6.18e-03 | 37 | 45 | 2 | M17400 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 6.51e-03 | 38 | 45 | 2 | MM14874 | |
| Pubmed | 2.79e-11 | 5 | 55 | 4 | 15647271 | ||
| Pubmed | 2.79e-11 | 5 | 55 | 4 | 19819941 | ||
| Pubmed | 2.79e-11 | 5 | 55 | 4 | 25141865 | ||
| Pubmed | 2.79e-11 | 5 | 55 | 4 | 8673135 | ||
| Pubmed | Smad7 is required for the development and function of the heart. | 8.37e-11 | 6 | 55 | 4 | 18952608 | |
| Pubmed | Control of early fate decisions in human ES cells by distinct states of TGFbeta pathway activity. | 8.37e-11 | 6 | 55 | 4 | 18393632 | |
| Pubmed | 8.37e-11 | 6 | 55 | 4 | 11169847 | ||
| Pubmed | 8.37e-11 | 6 | 55 | 4 | 11850197 | ||
| Pubmed | 8.37e-11 | 6 | 55 | 4 | 10400677 | ||
| Pubmed | 1.95e-10 | 7 | 55 | 4 | 15009097 | ||
| Pubmed | 1.95e-10 | 7 | 55 | 4 | 12370310 | ||
| Pubmed | Interaction with Smad4 is indispensable for suppression of BMP signaling by c-Ski. | 1.95e-10 | 7 | 55 | 4 | 14699069 | |
| Pubmed | 1.95e-10 | 7 | 55 | 4 | 10376010 | ||
| Pubmed | Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. | 1.95e-10 | 7 | 55 | 4 | 14580334 | |
| Pubmed | 1.95e-10 | 7 | 55 | 4 | 23933588 | ||
| Pubmed | Negative regulation of BMP/Smad signaling by Tob in osteoblasts. | 1.95e-10 | 7 | 55 | 4 | 11163184 | |
| Pubmed | A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension. | 3.90e-10 | 8 | 55 | 4 | 19211612 | |
| Pubmed | 3.90e-10 | 8 | 55 | 4 | 10531362 | ||
| Pubmed | 3.90e-10 | 8 | 55 | 4 | 10647776 | ||
| Pubmed | 3.90e-10 | 8 | 55 | 4 | 23804438 | ||
| Pubmed | 3.90e-10 | 8 | 55 | 4 | 12714599 | ||
| Pubmed | 3.90e-10 | 8 | 55 | 4 | 10708949 | ||
| Pubmed | 7.01e-10 | 9 | 55 | 4 | 19018011 | ||
| Pubmed | GATA4 is essential for bone mineralization via ERα and TGFβ/BMP pathways. | 7.01e-10 | 9 | 55 | 4 | 24932701 | |
| Pubmed | 7.01e-10 | 9 | 55 | 4 | 9759503 | ||
| Pubmed | 7.01e-10 | 9 | 55 | 4 | 30134160 | ||
| Pubmed | 7.01e-10 | 9 | 55 | 4 | 24816837 | ||
| Pubmed | Dullard/Ctdnep1 regulates endochondral ossification via suppression of TGF-β signaling. | 7.01e-10 | 9 | 55 | 4 | 25155999 | |
| Pubmed | 7.01e-10 | 9 | 55 | 4 | 10708948 | ||
| Pubmed | 1.17e-09 | 10 | 55 | 4 | 15221015 | ||
| Pubmed | Protein Arginine Methyltransferase PRMT1 Is Essential for Palatogenesis. | 1.17e-09 | 10 | 55 | 4 | 29986157 | |
| Pubmed | TGF-β signaling inhibits canonical BMP signaling pathway during palate development. | 1.17e-09 | 10 | 55 | 4 | 29247325 | |
| Pubmed | 1.17e-09 | 10 | 55 | 4 | 23620745 | ||
| Pubmed | Disruption of transforming growth factor-beta signaling in ELF beta-spectrin-deficient mice. | 1.17e-09 | 10 | 55 | 4 | 12543979 | |
| Pubmed | Smad2 and Smad3 Regulate Chondrocyte Proliferation and Differentiation in the Growth Plate. | 1.83e-09 | 11 | 55 | 4 | 27741240 | |
| Pubmed | 1.83e-09 | 11 | 55 | 4 | 24008158 | ||
| Pubmed | 2.74e-09 | 12 | 55 | 4 | 21538804 | ||
| Pubmed | 2.74e-09 | 12 | 55 | 4 | 17460146 | ||
| Pubmed | 2.74e-09 | 12 | 55 | 4 | 14656760 | ||
| Pubmed | Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes. | 3.74e-09 | 3 | 55 | 3 | 17381426 | |
| Pubmed | Blockade of Smad signaling by 3'-deoxyadenosine: a mechanism for its anti-fibrotic potential. | 3.74e-09 | 3 | 55 | 3 | 23439432 | |
| Pubmed | Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways. | 3.96e-09 | 13 | 55 | 4 | 19914168 | |
| Pubmed | Essential functions of Alk3 during AV cushion morphogenesis in mouse embryonic hearts. | 3.96e-09 | 13 | 55 | 4 | 16959237 | |
| Pubmed | Enhanced BMP signaling results in supernumerary tooth formation in USAG-1 deficient mouse. | 3.96e-09 | 13 | 55 | 4 | 18329379 | |
| Pubmed | Endoglin is required for myogenic differentiation potential of neural crest stem cells. | 3.96e-09 | 13 | 55 | 4 | 17628518 | |
| Pubmed | Matrix GLA protein, an inhibitory morphogen in pulmonary vascular development. | 5.54e-09 | 14 | 55 | 4 | 17670744 | |
| Pubmed | 5.54e-09 | 14 | 55 | 4 | 38951500 | ||
| Pubmed | 5.54e-09 | 14 | 55 | 4 | 25274628 | ||
| Pubmed | Loss of Smad4 in the scleraxis cell lineage results in postnatal joint contracture. | 5.54e-09 | 14 | 55 | 4 | 33248111 | |
| Pubmed | 5.54e-09 | 14 | 55 | 4 | 16790475 | ||
| Pubmed | 5.54e-09 | 14 | 55 | 4 | 16435884 | ||
| Pubmed | 7.54e-09 | 15 | 55 | 4 | 18548003 | ||
| Pubmed | 7.54e-09 | 15 | 55 | 4 | 23011393 | ||
| Pubmed | 7.54e-09 | 15 | 55 | 4 | 23946498 | ||
| Pubmed | 1.00e-08 | 16 | 55 | 4 | 21939397 | ||
| Pubmed | 1.50e-08 | 4 | 55 | 3 | 9111321 | ||
| Pubmed | 1.50e-08 | 4 | 55 | 3 | 19247629 | ||
| Pubmed | 1.50e-08 | 4 | 55 | 3 | 11016919 | ||
| Pubmed | Fussel-15, a novel Ski/Sno homolog protein, antagonizes BMP signaling. | 1.50e-08 | 4 | 55 | 3 | 17292623 | |
| Pubmed | Structural basis for the cooperative DNA recognition by Smad4 MH1 dimers. | 1.50e-08 | 4 | 55 | 3 | 21724602 | |
| Pubmed | A novel ability of Smad3 to regulate proteasomal degradation of a Cas family member HEF1. | 1.50e-08 | 4 | 55 | 3 | 11118211 | |
| Pubmed | Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase. | 1.50e-08 | 4 | 55 | 3 | 11158580 | |
| Pubmed | Functions of mammalian Smad genes as revealed by targeted gene disruption in mice. | 1.50e-08 | 4 | 55 | 3 | 10708952 | |
| Pubmed | 1.68e-08 | 18 | 55 | 4 | 23546880 | ||
| Pubmed | 1.68e-08 | 18 | 55 | 4 | 27720610 | ||
| Pubmed | 2.13e-08 | 19 | 55 | 4 | 23776616 | ||
| Pubmed | Fgf9 signaling regulates small intestinal elongation and mesenchymal development. | 2.66e-08 | 20 | 55 | 4 | 18653563 | |
| Pubmed | RAB23 coordinates early osteogenesis by repressing FGF10-pERK1/2 and GLI1. | 2.66e-08 | 20 | 55 | 4 | 32662771 | |
| Pubmed | 3.73e-08 | 5 | 55 | 3 | 18566469 | ||
| Pubmed | Carboxy-terminally truncated Gli3 proteins associate with Smads. | 3.73e-08 | 5 | 55 | 3 | 9843199 | |
| Pubmed | 3.73e-08 | 5 | 55 | 3 | 10092857 | ||
| Pubmed | 3.73e-08 | 5 | 55 | 3 | 12808092 | ||
| Pubmed | Opposing functions of ZEB proteins in the regulation of the TGFbeta/BMP signaling pathway. | 3.73e-08 | 5 | 55 | 3 | 12743038 | |
| Pubmed | 3.73e-08 | 5 | 55 | 3 | 27612439 | ||
| Pubmed | Two short segments of Smad3 are important for specific interaction of Smad3 with c-Ski and SnoN. | 3.73e-08 | 5 | 55 | 3 | 12426322 | |
| Pubmed | 3.73e-08 | 5 | 55 | 3 | 11387330 | ||
| Pubmed | E1A inhibits transforming growth factor-beta signaling through binding to Smad proteins. | 3.73e-08 | 5 | 55 | 3 | 10497242 | |
| Pubmed | USP15 is a deubiquitylating enzyme for receptor-activated SMADs. | 3.73e-08 | 5 | 55 | 3 | 21947082 | |
| Pubmed | The MH1 domain of Smad3 interacts with Pax6 and represses autoregulation of the Pax6 P1 promoter. | 3.73e-08 | 5 | 55 | 3 | 17251190 | |
| Pubmed | Myocardial smad4 is essential for cardiogenesis in mouse embryos. | 4.01e-08 | 22 | 55 | 4 | 17585069 | |
| Pubmed | 4.85e-08 | 23 | 55 | 4 | 21937600 | ||
| Pubmed | 5.81e-08 | 24 | 55 | 4 | 16943282 | ||
| Pubmed | 5.81e-08 | 24 | 55 | 4 | 34129836 | ||
| Pubmed | Neural crest cell-autonomous roles of fibronectin in cardiovascular development. | 5.81e-08 | 24 | 55 | 4 | 26552887 | |
| Pubmed | 6.91e-08 | 25 | 55 | 4 | 20019329 | ||
| Pubmed | 7.46e-08 | 6 | 55 | 3 | 11711431 | ||
| Pubmed | Repression of Smad transcriptional activity by PIASy, an inhibitor of activated STAT. | 7.46e-08 | 6 | 55 | 3 | 12904571 | |
| Pubmed | Structural basis for transcriptional coactivator recognition by SMAD2 in TGF-β signaling. | 7.46e-08 | 6 | 55 | 3 | 33323411 | |
| Pubmed | 7.46e-08 | 6 | 55 | 3 | 19135894 | ||
| Pubmed | Receptor-associated Mad homologues synergize as effectors of the TGF-beta response. | 7.46e-08 | 6 | 55 | 3 | 8774881 | |
| Pubmed | 7.46e-08 | 6 | 55 | 3 | 10890911 | ||
| Pubmed | 7.46e-08 | 6 | 55 | 3 | 21518886 | ||
| Pubmed | Novel roles of Pkd2 in male reproductive system development. | 7.46e-08 | 6 | 55 | 3 | 24951251 | |
| Pubmed | Smad proteins function as co-modulators for MEF2 transcriptional regulatory proteins. | 7.46e-08 | 6 | 55 | 3 | 11160896 | |
| Pubmed | Genetic variation in the TGF-β signaling pathway and colon and rectal cancer risk. | 7.46e-08 | 6 | 55 | 3 | 21068203 | |
| Pubmed | PRDM16/MEL1: a novel Smad binding protein expressed in murine embryonic orofacial tissue. | 7.46e-08 | 6 | 55 | 3 | 17467076 | |
| Pubmed | Repression of bone morphogenetic protein and activin-inducible transcription by Evi-1. | 7.46e-08 | 6 | 55 | 3 | 15849193 | |
| Pubmed | The TGFβ type I receptor TGFβRI functions as an inhibitor of BMP signaling in cartilage. | 8.15e-08 | 26 | 55 | 4 | 31311865 | |
| Pubmed | 1.11e-07 | 28 | 55 | 4 | 20346939 | ||
| Pubmed | 1.30e-07 | 7 | 55 | 3 | 15150273 | ||
| Interaction | TOB1 interactions | 1.26e-07 | 44 | 55 | 5 | int:TOB1 | |
| Interaction | AKR1B15 interactions | 6.85e-06 | 14 | 55 | 3 | int:AKR1B15 | |
| Interaction | RASL12 interactions | 2.12e-05 | 20 | 55 | 3 | int:RASL12 | |
| Interaction | RUNX3 interactions | 2.31e-05 | 61 | 55 | 4 | int:RUNX3 | |
| Interaction | HOXA13 interactions | 2.86e-05 | 22 | 55 | 3 | int:HOXA13 | |
| Interaction | ZNF8 interactions | 3.98e-05 | 70 | 55 | 4 | int:ZNF8 | |
| Interaction | RASD2 interactions | 4.24e-05 | 25 | 55 | 3 | int:RASD2 | |
| Interaction | ACSM2A interactions | 4.37e-05 | 4 | 55 | 2 | int:ACSM2A | |
| Interaction | ACSM2B interactions | 4.37e-05 | 4 | 55 | 2 | int:ACSM2B | |
| Interaction | PSMD11 interactions | 4.70e-05 | 353 | 55 | 7 | int:PSMD11 | |
| Interaction | MBD1 interactions | 5.79e-05 | 77 | 55 | 4 | int:MBD1 | |
| Interaction | SKI interactions | 7.48e-05 | 160 | 55 | 5 | int:SKI | |
| Interaction | SMC4 interactions | 1.14e-04 | 281 | 55 | 6 | int:SMC4 | |
| Interaction | ZEB2 interactions | 1.31e-04 | 95 | 55 | 4 | int:ZEB2 | |
| Interaction | GLI3 interactions | 1.48e-04 | 98 | 55 | 4 | int:GLI3 | |
| Interaction | RAB38 interactions | 1.52e-04 | 38 | 55 | 3 | int:RAB38 | |
| Interaction | GDF6 interactions | 1.52e-04 | 7 | 55 | 2 | int:GDF6 | |
| Interaction | COL3A1 interactions | 1.64e-04 | 39 | 55 | 3 | int:COL3A1 | |
| Interaction | SMAD5 interactions | 1.67e-04 | 101 | 55 | 4 | int:SMAD5 | |
| Interaction | MTA2 interactions | 1.73e-04 | 435 | 55 | 7 | int:MTA2 | |
| Interaction | MYOD1 interactions | 1.85e-04 | 194 | 55 | 5 | int:MYOD1 | |
| Interaction | KDM6B interactions | 1.86e-04 | 104 | 55 | 4 | int:KDM6B | |
| Interaction | TGIF1 interactions | 1.91e-04 | 41 | 55 | 3 | int:TGIF1 | |
| Interaction | BACH1 interactions | 2.39e-04 | 111 | 55 | 4 | int:BACH1 | |
| Interaction | RUNX1 interactions | 2.46e-04 | 324 | 55 | 6 | int:RUNX1 | |
| Interaction | CYP11A1 interactions | 2.60e-04 | 9 | 55 | 2 | int:CYP11A1 | |
| Interaction | KCTD13 interactions | NWD2 PLPPR4 TRIO MYO9A PRMT5 LARS1 NIPSNAP2 MTHFS AKR1B1 DCTN1 CNOT1 SLC4A1 | 3.10e-04 | 1394 | 55 | 12 | int:KCTD13 |
| Interaction | SKIL interactions | 3.12e-04 | 119 | 55 | 4 | int:SKIL | |
| Interaction | CDK8 interactions | 3.45e-04 | 222 | 55 | 5 | int:CDK8 | |
| Interaction | FOXO3 interactions | 3.65e-04 | 124 | 55 | 4 | int:FOXO3 | |
| Interaction | RUNX2 interactions | 3.88e-04 | 126 | 55 | 4 | int:RUNX2 | |
| Interaction | MED24 interactions | 4.12e-04 | 128 | 55 | 4 | int:MED24 | |
| Interaction | NCAPD2 interactions | 4.38e-04 | 234 | 55 | 5 | int:NCAPD2 | |
| Interaction | MXI1 interactions | 4.56e-04 | 55 | 55 | 3 | int:MXI1 | |
| Interaction | RGCC interactions | 4.74e-04 | 12 | 55 | 2 | int:RGCC | |
| Interaction | SMAD6 interactions | 4.81e-04 | 56 | 55 | 3 | int:SMAD6 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q33 | 4.79e-05 | 58 | 55 | 3 | chr7q33 | |
| Cytoband | 7p21.3 | 5.22e-04 | 28 | 55 | 2 | 7p21.3 | |
| Cytoband | 16p12.3 | 7.71e-04 | 34 | 55 | 2 | 16p12.3 | |
| Cytoband | 7q33 | 1.12e-03 | 41 | 55 | 2 | 7q33 | |
| Cytoband | 4p14 | 1.18e-03 | 42 | 55 | 2 | 4p14 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p14 | 2.96e-03 | 67 | 55 | 2 | chr4p14 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7p21 | 5.16e-03 | 89 | 55 | 2 | chr7p21 | |
| GeneFamily | SMAD family | 1.29e-09 | 8 | 39 | 4 | 750 | |
| GeneFamily | Aldo-keto reductases | 4.15e-06 | 15 | 39 | 3 | 399 | |
| GeneFamily | Acyl-CoA synthetase family | 2.33e-05 | 26 | 39 | 3 | 40 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 9.85e-03 | 206 | 39 | 3 | 682 | |
| Coexpression | TURJANSKI_MAPK1_AND_MAPK2_TARGETS | 1.90e-06 | 12 | 55 | 3 | M15804 | |
| Coexpression | GSE40068_CXCR5NEG_BCL6NEG_CD4_TCELL_VS_CXCR5POS_BCL6NEG_TFH_DN | 6.28e-05 | 200 | 55 | 5 | M9263 | |
| Coexpression | GSE7764_IL15_NK_CELL_24H_VS_SPLENOCYTE_UP | 6.28e-05 | 200 | 55 | 5 | M5725 | |
| Coexpression | GSE22886_NAIVE_BCELL_VS_BLOOD_PLASMA_CELL_UP | 6.28e-05 | 200 | 55 | 5 | M4440 | |
| Coexpression | GSE8621_LPS_STIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN | 6.28e-05 | 200 | 55 | 5 | M6983 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.76e-06 | 240 | 55 | 7 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k1_1000 | |
| Drug | propranolol glycol | 7.41e-07 | 8 | 55 | 3 | CID000037369 | |
| Drug | LY2109761 | 1.58e-06 | 10 | 55 | 3 | ctd:C530108 | |
| Drug | lys-val | 1.58e-06 | 10 | 55 | 3 | CID000140709 | |
| Drug | Glyceraldehyde | 1.58e-06 | 10 | 55 | 3 | ctd:D005985 | |
| Drug | Pentanones | 5.73e-06 | 2 | 55 | 2 | ctd:D010422 | |
| Drug | 4-hydroxyretinal | 5.73e-06 | 2 | 55 | 2 | ctd:C057180 | |
| Drug | 4-oxoretinaldehyde | 5.73e-06 | 2 | 55 | 2 | ctd:C099660 | |
| Drug | propioin | 5.73e-06 | 2 | 55 | 2 | ctd:C523189 | |
| Drug | dehydroretinal | 5.73e-06 | 2 | 55 | 2 | ctd:C017184 | |
| Drug | Nefopam hydrochloride [23327-57-3]; Up 200; 13.8uM; HL60; HT_HG-U133A | 7.69e-06 | 196 | 55 | 6 | 2355_UP | |
| Drug | Novobiocin sodium salt [1476-53-5]; Down 200; 6.4uM; HL60; HT_HG-U133A | 8.15e-06 | 198 | 55 | 6 | 2990_DN | |
| Drug | lanthanum carbide | 1.26e-05 | 19 | 55 | 3 | CID000123280 | |
| Drug | 2,4-hexadienal | 1.72e-05 | 3 | 55 | 2 | ctd:C079389 | |
| Drug | Acetoin | 1.72e-05 | 3 | 55 | 2 | ctd:D000093 | |
| Drug | 2,3-butylene glycol | 1.72e-05 | 3 | 55 | 2 | ctd:C026978 | |
| Drug | 4-hydroxy-2-nonenal | ZWILCH ZFP30 AKR1B10 S1PR2 MTHFS FEM1C AKR1B1 IFIT2 CCNK SMAD1 | 1.85e-05 | 798 | 55 | 10 | ctd:C027576 |
| Drug | acetol | 3.33e-05 | 26 | 55 | 3 | CID000008299 | |
| Drug | 5-Isothiocyanatoalrestatin | 3.43e-05 | 4 | 55 | 2 | CID000124861 | |
| Drug | 5-azidoalrestatin | 3.43e-05 | 4 | 55 | 2 | CID000128442 | |
| Drug | 5-(3-Thienyl)tetrazol-1-yl)acetic acid | 3.43e-05 | 4 | 55 | 2 | CID003035658 | |
| Drug | FR-62765 | 3.43e-05 | 4 | 55 | 2 | CID000128354 | |
| Drug | M7HEQ | 3.43e-05 | 4 | 55 | 2 | CID006452329 | |
| Drug | 2,5-DHBQOP | 3.43e-05 | 4 | 55 | 2 | CID000069213 | |
| Drug | NAP-HEX-Q | 3.43e-05 | 4 | 55 | 2 | CID005487149 | |
| Drug | AC1NUTWC | 3.43e-05 | 4 | 55 | 2 | CID005460914 | |
| Drug | WF-2421 | 3.43e-05 | 4 | 55 | 2 | CID000195567 | |
| Drug | danshenol B | 3.43e-05 | 4 | 55 | 2 | CID003083515 | |
| Drug | 4-chloro-3-hydroxybutanoate | 3.43e-05 | 4 | 55 | 2 | CID010129995 | |
| Drug | iodomethanesulfonamide | 3.43e-05 | 4 | 55 | 2 | CID000519939 | |
| Drug | salviaflaside | 3.43e-05 | 4 | 55 | 2 | CID006438919 | |
| Drug | matteuorienate A | 3.43e-05 | 4 | 55 | 2 | CID000190958 | |
| Drug | zopolrestat | 3.74e-05 | 27 | 55 | 3 | CID000001613 | |
| Drug | M79175 | 5.70e-05 | 5 | 55 | 2 | CID000115090 | |
| Drug | xanthone-2 | 5.70e-05 | 5 | 55 | 2 | CID005384285 | |
| Drug | 4'-deoxydoxorubicin | 5.70e-05 | 5 | 55 | 2 | CID000044554 | |
| Drug | AC1NE042 | 5.70e-05 | 5 | 55 | 2 | CID004634410 | |
| Drug | AC1L4VGL | 5.70e-05 | 5 | 55 | 2 | CID000213726 | |
| Drug | 4-chloro-3-nitrobenzaldehyde | 5.70e-05 | 5 | 55 | 2 | CID000085505 | |
| Drug | 2,3-hexanedione | 5.70e-05 | 5 | 55 | 2 | ctd:C043231 | |
| Drug | ICI 105552 | 5.70e-05 | 5 | 55 | 2 | CID000133677 | |
| Drug | 2-(2,3,6-Trihydroxy-4-carboxyphenyl)ellagic acid | 5.70e-05 | 5 | 55 | 2 | CID006918808 | |
| Drug | ICI 222155 | 5.70e-05 | 5 | 55 | 2 | CID000195716 | |
| Drug | DN-108 | 5.70e-05 | 5 | 55 | 2 | CID000183791 | |
| Drug | AD-5467 | 5.70e-05 | 5 | 55 | 2 | CID000197383 | |
| Drug | BAL-ARI8 | 5.70e-05 | 5 | 55 | 2 | CID000130098 | |
| Drug | 3-deoxyglucosone | 5.72e-05 | 31 | 55 | 3 | CID000114839 | |
| Drug | 3'-deoxyguanosine | 7.57e-05 | 34 | 55 | 3 | CID000165138 | |
| Drug | Mcat | 8.26e-05 | 35 | 55 | 3 | CID003080785 | |
| Drug | phenanthrene trans-1,2-dihydrodiol | 8.54e-05 | 6 | 55 | 2 | CID000115062 | |
| Drug | ICI 215918 | 8.54e-05 | 6 | 55 | 2 | CID000129688 | |
| Drug | AC1L28UN | 8.54e-05 | 6 | 55 | 2 | CID000068017 | |
| Drug | M16287 | 8.54e-05 | 6 | 55 | 2 | CID000188399 | |
| Drug | p225 | 8.54e-05 | 6 | 55 | 2 | CID000014589 | |
| Drug | ADN-138 | 8.54e-05 | 6 | 55 | 2 | CID000127323 | |
| Drug | BAPSG | 8.54e-05 | 6 | 55 | 2 | CID000130998 | |
| Drug | 1,2,4-triazol-3-one | 8.54e-05 | 6 | 55 | 2 | CID011073339 | |
| Drug | capillarisin | 8.54e-05 | 6 | 55 | 2 | CID005281342 | |
| Drug | 3,5-dichlorosalicylic acid | 8.54e-05 | 6 | 55 | 2 | CID000009445 | |
| Drug | 1,2-dithiole-3-thione | 1.15e-04 | 39 | 55 | 3 | CID000068296 | |
| Drug | Cytochalasin D | 1.15e-04 | 39 | 55 | 3 | ctd:D015638 | |
| Drug | 1,3,2-dioxaborolan-2-ol | 1.17e-04 | 104 | 55 | 4 | CID005289333 | |
| Drug | 4-nitrobenzaldehyde | 1.19e-04 | 7 | 55 | 2 | ctd:C029915 | |
| Drug | myrciacitrin I | 1.19e-04 | 7 | 55 | 2 | CID000183137 | |
| Drug | friedelane | 1.19e-04 | 7 | 55 | 2 | CID000634354 | |
| Drug | 5-methoxypsoralen | 1.19e-04 | 7 | 55 | 2 | ctd:C022909 | |
| Drug | 3-formylbenzoic acid | 1.19e-04 | 7 | 55 | 2 | CID000012077 | |
| Drug | tetramethylene glutaric acid | 1.19e-04 | 7 | 55 | 2 | CID000085558 | |
| Drug | guaijaverin | 1.19e-04 | 7 | 55 | 2 | CID005317847 | |
| Drug | desmanthin-1 | 1.19e-04 | 7 | 55 | 2 | CID005316590 | |
| Drug | rosiglitazone; Down 200; 10uM; MCF7; HT_HG-U133A | 1.21e-04 | 200 | 55 | 5 | 6992_DN | |
| Drug | AC1L1FQE | 1.54e-04 | 43 | 55 | 3 | CID000003349 | |
| Drug | erythritol 4-phosphate | 1.59e-04 | 8 | 55 | 2 | CID000192838 | |
| Drug | 4-hydroxynonanoate | 1.59e-04 | 8 | 55 | 2 | CID000134653 | |
| Drug | Risarestat | 1.59e-04 | 8 | 55 | 2 | CID000133264 | |
| Drug | 6-pyridoxyllysine | 1.59e-04 | 8 | 55 | 2 | CID000160700 | |
| Drug | 1,2-diaminoguanidine | 1.59e-04 | 8 | 55 | 2 | CID000170039 | |
| Drug | 20-CHO-LTB4 | 1.59e-04 | 8 | 55 | 2 | CID006449839 | |
| Drug | CP-166,572 | 1.59e-04 | 8 | 55 | 2 | CID000132302 | |
| Drug | LDN 193189 | 1.59e-04 | 8 | 55 | 2 | ctd:C554430 | |
| Drug | alcophosphamide | 1.59e-04 | 8 | 55 | 2 | CID000098612 | |
| Drug | eutypine | 1.59e-04 | 8 | 55 | 2 | CID000129326 | |
| Drug | SG-210 | 1.59e-04 | 8 | 55 | 2 | CID000132542 | |
| Drug | NSC633676 | 1.59e-04 | 8 | 55 | 2 | CID000133894 | |
| Drug | 3 Na | 1.59e-04 | 8 | 55 | 2 | CID000157838 | |
| Drug | AC1L1K15 | 2.03e-04 | 120 | 55 | 4 | CID000005293 | |
| Drug | AL3152 | 2.04e-04 | 9 | 55 | 2 | CID000159501 | |
| Drug | AC1Q5HJP | 2.04e-04 | 9 | 55 | 2 | CID000000067 | |
| Drug | 3-deoxyfructose | 2.04e-04 | 9 | 55 | 2 | CID003080627 | |
| Drug | potassium amyl xanthate | 2.04e-04 | 9 | 55 | 2 | CID000017635 | |
| Drug | metyrapol | 2.04e-04 | 9 | 55 | 2 | CID000161210 | |
| Drug | mycaminose | 2.55e-04 | 10 | 55 | 2 | CID000160504 | |
| Drug | 2,3-hexanedione | 2.55e-04 | 10 | 55 | 2 | CID000019707 | |
| Drug | Hexanones | 2.55e-04 | 10 | 55 | 2 | ctd:D006588 | |
| Drug | 3-fluoro-3-deoxy-D-glucose | 2.55e-04 | 10 | 55 | 2 | CID000122305 | |
| Drug | protocatechualdehyde | 2.55e-04 | 10 | 55 | 2 | ctd:C005581 | |
| Drug | Dihydroxydihydrobenzopyrenes | 3.11e-04 | 11 | 55 | 2 | ctd:D004101 | |
| Drug | Wen-pi-tang-Hab-Wu-ling-san | 3.11e-04 | 11 | 55 | 2 | ctd:C521629 | |
| Drug | chlordecone alcohol | 3.11e-04 | 11 | 55 | 2 | CID000013946 | |
| Drug | NSC 60462 | 3.11e-04 | 11 | 55 | 2 | CID000097943 | |
| Drug | phytochromobilin | 3.11e-04 | 11 | 55 | 2 | CID006449958 | |
| Disease | X-21319 measurement | 3.17e-06 | 2 | 53 | 2 | EFO_0800807 | |
| Disease | X-11478 measurement | 9.49e-06 | 3 | 53 | 2 | EFO_0021242 | |
| Disease | aldose reductase measurement | 1.89e-05 | 4 | 53 | 2 | EFO_0801364 | |
| Disease | 3-hydroxyhexanoate measurement | 3.15e-05 | 5 | 53 | 2 | EFO_0800378 | |
| Disease | indoleacetoylcarnitine measurement | 4.73e-05 | 6 | 53 | 2 | EFO_0800106 | |
| Disease | Loeys-Dietz Syndrome | 6.61e-05 | 7 | 53 | 2 | C2697932 | |
| Disease | symmetrical dimethylarginine measurement | 1.13e-04 | 9 | 53 | 2 | EFO_0006523 | |
| Disease | white matter growth measurement | 1.13e-04 | 9 | 53 | 2 | EFO_0009335 | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 2.44e-04 | 13 | 53 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | Left Ventricle Remodeling | 6.50e-04 | 21 | 53 | 2 | C0600520 | |
| Disease | Ventricular Remodeling | 6.50e-04 | 21 | 53 | 2 | C0600519 | |
| Disease | Lynch syndrome (is_implicated_in) | 8.52e-04 | 24 | 53 | 2 | DOID:3883 (is_implicated_in) | |
| Disease | Cocaine-Related Disorders | 1.23e-03 | 117 | 53 | 3 | C0236736 | |
| Disease | Cocaine Abuse | 1.56e-03 | 127 | 53 | 3 | C0009171 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| INYPKVSASVHQYNK | 471 | Q6UWY0 | |
| YKCQHQQVNESEPVY | 91 | P12319 | |
| NVEPLTKAIKYYQHL | 716 | Q14203 | |
| IKIFQDHPLQKTYNY | 541 | P02730 | |
| VIRYNSDLVQKYHPC | 131 | Q06187 | |
| ELQQHVKSVTAPYKY | 526 | Q08AH3 | |
| CFVLKHPQIQKESQY | 381 | Q7Z5R6 | |
| HPQIQKESQYIKYLC | 386 | Q7Z5R6 | |
| QVEHPYQFLLKYAKQ | 156 | O75909 | |
| LKYKPVTNQVECHPY | 176 | O60218 | |
| ECHPYLTQEKLIQYC | 186 | O60218 | |
| FKTQQYYNVLKQICP | 181 | Q96CM8 | |
| CKYIYQKNGDPLHIS | 1146 | Q8WZ64 | |
| ECHPYLTQEKLIQYC | 186 | P15121 | |
| VNYRCLVQSYPKKIH | 476 | Q9ULI1 | |
| KYPKNIVENHTAYLV | 616 | Q09MP3 | |
| SNLYKLQFHNVKPEC | 71 | O75323 | |
| PKSHQKCRQYYPVTI | 286 | Q14699 | |
| IYLPNVKVLCLNYNH | 1136 | Q6ZRR7 | |
| PCTLEQDHFKKQTIY | 456 | Q96JP0 | |
| YLKRCLQHQEVKPYT | 156 | P49914 | |
| LHKVQQYCYELAPDQ | 406 | Q5TKA1 | |
| VRKDYKYVQCGVQPQ | 356 | Q9P1W3 | |
| KIYSIYHQPNKNQTK | 446 | Q9HCI6 | |
| LKQLNHPNVIKYYAS | 86 | Q8TDX7 | |
| KCLYNVSAYDQKPQV | 116 | P50549 | |
| KYEQGYQKSHPTIQL | 916 | Q8IVU3 | |
| QCPKAAQKYVERIHY | 126 | P30519 | |
| LVVLYHYVAVNNPKK | 21 | P0C6T2 | |
| PRYQYLINHKEKCQA | 71 | Q9BYG0 | |
| IYVPQNVYCIHVDEK | 131 | Q6ZNI0 | |
| KTKYHYQPQLDQQTL | 61 | Q5SVJ3 | |
| PIKYSQYQQAIYKCL | 331 | O14744 | |
| KKALEYIPNNAYLHC | 271 | P09913 | |
| KYANETVNPYLVIKC | 531 | Q9Y6Q1 | |
| PNKVQEHYNYTKETL | 11 | O95136 | |
| LYKKNPKLLNQLQYC | 441 | P12081 | |
| YNVKQLKLHCTVPAY | 511 | Q969X6 | |
| LKNIPEKHSQVAQYY | 191 | Q96GJ1 | |
| KCKNSHLYPLIETQY | 941 | Q9UPZ6 | |
| QKPSHCTIYVAKNYP | 931 | Q9P2J5 | |
| LKKHCPNQYQIYSES | 86 | Q8N8I0 | |
| SKQKEVCINPYHYKR | 116 | Q99717 | |
| KQKEVCINPYHYKRV | 116 | Q15797 | |
| LKYKPVTNQVECHPY | 176 | C9JRZ8 | |
| ECHPYLTQEKLIQYC | 186 | C9JRZ8 | |
| ELQQHVKSVTAPYKY | 526 | Q68CK6 | |
| FKNRLKDYPQYCQHL | 961 | A5YKK6 | |
| TRITQYKNHPVDVYC | 296 | Q7Z2D5 | |
| KETYRCIKQVHYTLP | 266 | Q9H4B4 | |
| LTQICIKYYKQNPLD | 491 | Q9H900 | |
| IKYYKQNPLDEQHIF | 496 | Q9H900 | |
| PLYQKSHNREKPYEC | 146 | Q9Y2G7 | |
| KKDEVCVNPYHYQRV | 156 | Q15796 | |
| KKDEVCVNPYHYQRV | 116 | P84022 | |
| LINHQGIYTNEKPYK | 186 | Q96NG8 | |
| KVYALYRQLLQHECP | 106 | Q86UK7 | |
| YCQNKPKSEHIVSEY | 2061 | O75962 | |
| VCGKIFNQKQYIVYH | 261 | Q0VGE8 | |
| KQPEEYHYLNQITKK | 356 | B2RTY4 |